Quantcast

Latest Rember Stories

2014-01-06 04:21:53

Clinical research centers added to allow more patients to access a tau-based investigational treatment for mild to moderate Alzheimer's disease ABERDEEN, Scotland, Jan. 6, 2014 /PRNewswire/ -- TauRx Therapeutics Ltd, a clinical-stage biopharmaceutical company developing a novel treatment for Alzheimer's disease, has expanded its international clinical trials by adding new research centers across the U.S. The addition of 35 clinical research centers means that more patients suffering...

2009-09-30 10:55:31

Laboratory study shows drug targets chaperone Hsp70 to reduce Alzheimer's protein Inhibiting the protein Hsp70 rapidly reduces brain levels of tau, a protein associated with Alzheimer's disease when it builds up abnormally inside nerve cells affecting memory, neuroscientists at the University of South Florida found. The study is reported online Sept. 29 in the Journal of Neuroscience. "Now that we've discovered that targeting the chaperone protein Hsp70 can clear tau, it could be helpful in...

2008-08-22 03:00:44

By Donovan, Paul Dementia "Hi, mate, how are you?" is a greeting that has come to haunt me. It came from my dad on a recent visit to the care home where he lives, offering a glimpse of what he used to be like. Dad suffers with dementia. When the family visits he sits, occasionally acknowledging us, but usually just fiddling with things. At his worst, he appears to be in a sort of torment. News that the University of Aberdeen has developed Rember, a drug that can slow the progression of...

2008-08-04 15:00:16

SCOTS scientists have developed a drug they say can halt the devastating progress of Alzheimer's disease. It could prove at least twice as effective in treating the disease as current medicines. The drug, known as rember, slows progression of the disease by as much as 81per cent. People taking it for 50 weeks had a slower decline in blood flow to the parts of the brain that are important for memory than those taking a dummy pill. Rember is the first drug to act on the 'tangles' that...

2008-08-02 00:00:06

By DOMINIC JEFF Herald Reporter Alzheimer's support workers in Plymouth have cautiously welcomed news of a new drug which may halt the progression of the disease. Trials of the drug Rember by Aberdeen University researchers showed an 81 per cent difference in the rate of mental decline among those taking the treatment. Ian Sherriff, chairman of the Plymouth and district branch of the Alzheimer's Society, said: "It's good news. It's clearly still in a testing stage, but the figures...

2008-07-31 12:00:15

By CHRIS THORNTON A NEW drug hailed as a potential breakthrough in the fight against Alzheimer's is still years away from being available in Northern Ireland, an MP whose husband suffers from the disease has warned. Lady Sylvia Hermon said revelations this week about trials of the drug Rember - which has slowed the disease remarkably in a clinical trial - are "truly encouraging". But she said "the major prize" of preventing the killer disease is still elusive. Lady Sylvia has spoken...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related